Page last updated: 2024-09-05

3,3',5-triiodothyronamine and Thyrotoxicosis

3,3',5-triiodothyronamine has been researched along with Thyrotoxicosis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bianchini, A; Bizzarri, G; Graziano, FM; Guglielmi, R; Pacella, CM; Palma, E; Papini, E; Petrucci, L; Poggi, M; Rinaldi, R; Toscano, V1

Other Studies

1 other study(ies) available for 3,3',5-triiodothyronamine and Thyrotoxicosis

ArticleYear
Percutaneous ethanol injection treatment in benign thyroid lesions: role and efficacy.
    Thyroid : official journal of the American Thyroid Association, 2004, Volume: 14, Issue:2

    Topics: Administration, Cutaneous; Cost-Benefit Analysis; Cysts; Ethanol; Health Care Costs; Humans; Injections; Predictive Value of Tests; Prognosis; Thyroid Diseases; Thyroid Nodule; Thyrotoxicosis; Thyrotropin; Thyroxine; Treatment Outcome; Triiodothyronine

2004